|
HN1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8480000000265E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.79529999983141E-07 |
| Normal-vs-Stage2 |
1.090270E-02 |
| Normal-vs-Stage3 |
1.621610E-03 |
| Normal-vs-Stage4 |
3.817700E-03 |
| Stage1-vs-Stage2 |
2.143800E-01 |
| Stage1-vs-Stage3 |
8.024300E-02 |
| Stage1-vs-Stage4 |
2.020600E-01 |
| Stage2-vs-Stage3 |
9.352000E-01 |
| Stage2-vs-Stage4 |
8.819400E-01 |
| Stage3-vs-Stage4 |
9.232600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.25340000004471E-07 |
| Normal-vs-AfricanAmerican |
2.007600E-01 |
| Normal-vs-Asian |
1.599580E-01 |
| Caucasian-vs-AfricanAmerican |
3.602300E-02 |
| Caucasian-vs-Asian |
7.477600E-01 |
| AfricanAmerican-vs-Asian |
6.488400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57849999999904E-05 |
| Normal-vs-Female |
2.09159999999819E-05 |
| Male-vs-Female |
8.203200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.071020E-01 |
| Normal-vs-Age(41-60Yrs) |
1.75280999999972E-05 |
| Normal-vs-Age(61-80Yrs) |
4.16680000003833E-06 |
| Normal-vs-Age(81-100Yrs) |
1.343400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.941600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.402800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.241800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.940600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.206200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.993200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.969510E-02 |
| Normal-vs-Grade 2 |
6.24299999474331E-08 |
| Normal-vs-Grade 3 |
1.010540E-04 |
| Normal-vs-Grade 4 |
1.268600E-01 |
| Grade 1-vs-Grade 2 |
8.010600E-01 |
| Grade 1-vs-Grade 3 |
7.198200E-01 |
| Grade 1-vs-Grade 4 |
1.810990E-01 |
| Grade 2-vs-Grade 3 |
8.350300E-02 |
| Grade 2-vs-Grade 4 |
6.805200E-04 |
| Grade 3-vs-Grade 4 |
2.965700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.8618998544091E-11 |
| Normal-vs-ccB subtype |
1.940220E-02 |
| ccA subtype-vs-ccB subtype |
4.04940000000575E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.427100E-04 |
| Normal-vs-N1 |
4.251900E-02 |
| N0-vs-N1 |
3.596800E-01 |
|
|
